<?xml version="1.0" encoding="UTF-8"?>
<p id="para100">We therefore designed the MARIETTA trial, which aimed to assess an intensive, CNS-directed chemoimmunotherapy consolidated by autologous HSCT in patients with secondary CNS lymphoma. Here, we report safety and activity results of this trial.</p>
